Hence, modulation of NR4A1 and NR4A2 expression by Rasd1 and NonO could have a major impact on the circadian control, and disruption of this process can give rise to metabolic diseases and cancer development [78], [79], [80], [81]. This evidence concerns the gene NR4A2 and Other metabolic disease.